AMANDA BIBBS: Open Payments
NPI 1609396944 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 44 payments from 8 companies in 2025. Trend: 2023 $788 · 2024 $687 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $291 |
| UCB, Inc. | 4 | $205 |
| GlaxoSmithKline, LLC. | 4 | $183 |
| ABBVIE INC. | 10 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Janssen Biotech, Inc. | 3 | $47 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
Products named: Bimzelx, BENLYSTA, OTEZLA, COSENTYX, SKYRIZI, SAPHNELO, RINVOQ, TREMFYA.
Industry payments across OK — which companies pay providers there.
